The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Travel stocks soar as encouraging vaccine study lifts Europe

Wed, 15th Jul 2020 09:41

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Euro zone blue-chips hit highest since March 5

* Italy's Atlantia soars as end of concession dispute nears

* Sweden's SEB slips as loan loss provision surges

* All eyes on ECB meeting, EU summit later this week
(Updates to market close)

By Sruthi Shankar

July 15 (Reuters) - European stocks closed at over a
five-week high on Wednesday, with travel stocks surfing a wave
of optimism following reports of progress in developing a
COVID-19 vaccine.

Hard-hit airline stocks like British Airways-owner IAG
, Ryanair and Lufthansa rose between
9.7% and 10.7%, while cruise operator Carnival Plc
jumped 11.4%.

The travel & leisure index surged 6.1% to lead
sectoral gains, but still remains the worst performer in Europe
this year with a 33% plunge as the coronavirus pandemic brought
global travel to a halt.

The pan-European STOXX 600 rose 1.8%, closing just
short of levels last seen in early March, while euro zone
blue-chips jumped 1.7% to hit their highest level
since March 5.

Investors were encouraged by an early-stage study on U.S.
biotech firm Moderna Inc's experimental vaccine for
COVID-19 that provoked immune responses.

Meanwhile, AstraZeneca jumped 5.2% after a report
said positive news on the University of Oxford's potential
COVID-19 vaccine that has been licensed to the drugmaker could
be announced as soon as Thursday.

"Our central scenario is that a vaccine would be broadly
available from the second quarter of next year, or the fourth
quarter of this year in our upside scenario," Mark Haefele,
chief investment officer of UBS Global Wealth Management, told
clients.

"Various potential treatment options are also in the
pipeline, raising hopes that societies can cope with the
pandemic without full shutdowns."

Expectations were also high among investors heading into an
EU summit later this week that leaders will agree on a recovery
fund of 750 billion euros for pandemic-hammered economies.

The European Central Bank concludes its policy meeting on
Thursday although no major announcements are expected.

Among individual movers, Swedish telecom operator Tele2 AB
gained 2.9% as it reaffirmed its 2020 earnings
outlook and plans for an extra shareholder payout.

The world's largest fish farmer Mowi ASA jumped
6.8% as harvest volumes beat its own forecast. Shares in peer
Salmar rose 2.2%.

The top gainer on the STOXX 600 was Atlantia SpA,
which shot up 26.7% after the Italian infrastructure group and
its unit Autostrade made the government new offers to settle
their long-running dispute.

Semiconductor equipment maker ASML Holding NV
declined 3.7% as it reported quarterly profit below estimates,
but forecast overall growth for 2020.

Swedish bank SEB AB fell 1.6% after reporting a
smaller-than-expected fall in net quarterly profit, but credit
loss provisions surged. Handelsbanken AB also dropped
2.6%.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak
Dasgupta and Catherine Evans)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.